LU83363A1 - Compositions antitumeurs - Google Patents

Compositions antitumeurs Download PDF

Info

Publication number
LU83363A1
LU83363A1 LU83363A LU83363A LU83363A1 LU 83363 A1 LU83363 A1 LU 83363A1 LU 83363 A LU83363 A LU 83363A LU 83363 A LU83363 A LU 83363A LU 83363 A1 LU83363 A1 LU 83363A1
Authority
LU
Luxembourg
Prior art keywords
lactic acid
anisidide
acridinylamino
methanesulfone
water
Prior art date
Application number
LU83363A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83363A1 publication Critical patent/LU83363A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU83363A 1980-05-16 1981-05-15 Compositions antitumeurs LU83363A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14705680 1980-05-16
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (1)

Publication Number Publication Date
LU83363A1 true LU83363A1 (fr) 1982-01-20

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83363A LU83363A1 (fr) 1980-05-16 1981-05-15 Compositions antitumeurs

Country Status (21)

Country Link
US (1) US4360523A (cs)
JP (1) JPS579716A (cs)
AT (1) AT374682B (cs)
AU (1) AU543726B2 (cs)
BE (1) BE888832A (cs)
CA (1) CA1160571A (cs)
CH (1) CH647677A5 (cs)
DE (1) DE3119510A1 (cs)
DK (1) DK159376C (cs)
FI (1) FI70793C (cs)
FR (1) FR2482458A1 (cs)
GB (1) GB2076288B (cs)
GR (1) GR75658B (cs)
IE (1) IE51285B1 (cs)
IT (1) IT1170970B (cs)
LU (1) LU83363A1 (cs)
NL (1) NL8102362A (cs)
NZ (1) NZ196985A (cs)
SE (1) SE460457B (cs)
YU (1) YU44831B (cs)
ZA (1) ZA813188B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3844518A1 (de) * 1988-03-23 1989-10-05 Karl Heinz Dr Med Thiel Verwendung von aminochinolinen und aminopyridinen zur iontophoretischen behandlung maligner tumore
DE3819842C1 (cs) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006002887A1 (en) * 2004-06-29 2006-01-12 Baxter International Inc. Aqueous drink solution of indibulin (d-24851) and an organic acid
MX2007005434A (es) * 2004-11-08 2007-07-10 Baxter Int Composiciones de nanoparticulado de inhibidor de tubulina.
EP2091532A1 (en) * 2006-11-28 2009-08-26 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
US10434077B2 (en) 2014-03-31 2019-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
NL8102362A (nl) 1981-12-16
JPH0136445B2 (cs) 1989-07-31
AU7029181A (en) 1981-11-19
JPS579716A (en) 1982-01-19
DE3119510A1 (de) 1982-02-25
GB2076288A (en) 1981-12-02
YU112381A (en) 1985-03-20
FI811474L (fi) 1981-11-17
GB2076288B (en) 1983-12-14
IT1170970B (it) 1987-06-03
IE811092L (en) 1981-11-16
YU44831B (en) 1991-04-30
CA1160571A (en) 1984-01-17
CH647677A5 (de) 1985-02-15
AT374682B (de) 1984-05-25
NZ196985A (en) 1983-06-17
DK216681A (da) 1981-11-17
AU543726B2 (en) 1985-05-02
BE888832A (fr) 1981-11-16
FR2482458B1 (cs) 1984-12-14
IT8148467A0 (it) 1981-05-14
DK159376C (da) 1991-03-25
FI70793B (fi) 1986-07-18
ZA813188B (en) 1982-05-26
GR75658B (cs) 1984-08-02
SE460457B (sv) 1989-10-16
ATA221181A (de) 1983-10-15
IE51285B1 (en) 1986-11-26
US4360523A (en) 1982-11-23
SE8103071L (sv) 1981-11-17
FR2482458A1 (fr) 1981-11-20
DK159376B (da) 1990-10-08
DE3119510C2 (cs) 1991-03-07
FI70793C (fi) 1986-10-27

Similar Documents

Publication Publication Date Title
EP0078785B1 (fr) Sels d'acide valproîque, leur préparation et leur utilisation
CA2680433C (fr) Nouvelle composition a base d'oxime de cholest-4-en-3-one
JPS60208979A (ja) シクロデキストリンとの複合化包接化合物、その製造方法および該化合物を含有する抗炎症、鎮痛および解熱効果を有する医薬組成物
FR2613619A1 (fr) Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
FR2602141A1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
EP0399903A1 (fr) Nouvelles compositions à base d'imipramine
JP2006083171A (ja) プロゲステロンを有する新規の注入可能処方
JPS5931713A (ja) オキシカム誘導体含有医薬組成物
LU83363A1 (fr) Compositions antitumeurs
FR2775901A1 (fr) Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
WO1994012193A1 (fr) Combinaison de cisplatine avec l'oxaliplatine
LU82360A1 (fr) Compositions injectables a base d'oxytetracycline
CA2340020A1 (fr) Utilisation de derives de la camptothecine, avec une toxicite gastro-intestinale reduite
FR2613223A1 (fr) Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
CN105899485B (zh) 多不饱和羟基脂肪酸的药学上可接受的盐
FR2772272A1 (fr) Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
HU229409B1 (en) Compositions comprising modafinil compounds
LU85812A1 (fr) Forme dosee d'etoposide a usage oral
JP2007106736A (ja) 注射用の医薬組成物
FR2753097A1 (fr) Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
LU83081A1 (fr) Compositions antitumeurs
BE887220A (fr) Compositions antitumeurs
EP0986390B1 (fr) Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine
US4425348A (en) Antitumor compositions
CH648302A5 (fr) Lactates du 4'-(9-acridinylamino-methanesulf-m-anidiside, leur procede de production et composition pharmaceutique les contenant.